
Johnson & Johnson's JNJ.N Covid-19 vaccine, called Ad26.COV2.S, was well-tolerated by subjects at two dosing instances in early-to-mid stage coronavirus clinical trials.
from Pocket https://www.independent.co.uk/news/world/americas/coronavirus-vaccine-trials-covid-19-johnson-b624918.html
via TV Aerial Installers Wakefield
No comments:
Post a Comment